MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SMITH, A. P.
Right arrow Articles by LOH, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SMITH, A. P.
Right arrow Articles by LOH, H. H.

Molecular Pharmacology, Vol 16, 757-766, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Multiple Molecular Forms of Stereospecific Opiate Binding

ANDREW P. SMITH 1 and HORACE H. LOH 1

1 Department of Pharmacology, University of California, San Francisco, California 94122

When brain membranes were incubated in vitro with 3H-enkephalinamide, then extracted with the non-ionic detergent Brij 36-T, up to 75% of the levorphanol-displaceable radioactivity was released in a bound form. Analysis of the binding material by gel filtration revealed a broad peak of 100,000-500,000 molecular weight, and several other species of less than 20,000 molecular weight. Iso-electric focusing resolved the binding components into two major peaks of pI’s about 8.4 and 3.2, and several minor species in the pI range 8.3-6.5; both high and low molecular weight material appeared to be present in the two major pI peaks. All of the stereospecific binding components identified by iso-electric focusing appeared to behave similarly with respect to several competing unlabeled drugs, and to Na+ ion. Comparable heterogeneity was observed in material stereospecifically binding 3H-betaH-endorphin, 3H-etorphine, and 3H-naloxone, and incubation of Brij-extracted 3H-betaH-endorphin-binding membranes with 10 mM dimethyl suberimidate covalently labeled a broad range of species of 2-200 x 103 molecular weight. These results demonstrate that many distinct brain membrane components can bind opiates stereospecifically in vitro; these components may include lipids as well as proteins.

Note:
ACKNOWLEDGMENT We thank Drs. Richard Houghten and C. H. Li for the gift of tritiated betaH-endorphin.

Submitted on May 8, 1979
Accepted on July 19, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics